iPad Utilization in Pharma Sales & Managed Markets Teams: Top Challenges & Success Factors - KXNet.com - Bismarck/Minot/Williston/Dickinson-KXNEWS,ND

iPad Utilization in Pharma Sales & Managed Markets Teams: Top Challenges & Success Factors

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Best Practices, LLC

CHAPEL HILL, N.C., May 5, 2014 /PRNewswire/ -- Sales and managed markets teams at bio-pharma and medical device companies are increasingly utilizing more popular technological innovations. Despite the many benefits that are associated with implementing these devices, deploying iPads into the field also requires significant planning, resources and training to make the investment a success.

There are various challenges that organizations can encounter when deploying iPads to large customer-facing commercial groups. According to recent research by benchmarking firm Best Practices, LLC, 42% of leaders agree that having a structured training plan is one of the most effective ways to overcome the challenges that they face when implementing iPads. Having proper training will make reps or account managers more comfortable with technology, prompting them to use the device actively.

The study, "iPad Utilization in Pharma: Top Challenges and Success Factors for Sales and Managed Markets Teams," provides insights that can serve as a reference point for sales and managed markets leaders regarding the deployment of iPads. The research also outlines valuable findings on iPad deployment challenges, lessons learned and best practices.

Key study topics include:

  • iPad Deployment Challenges
  • iPad Deployment Best Practices

Best Practices, LLC engaged 59 Sales & Training leaders at 40 companies through a benchmarking survey instrument. All participants share leadership and oversight of Sales, Training, and Commercial groups at their healthcare organizations.

This document is featured in Best Practices, LLC's Database. Best Practice Database documents include benchmarks and insights gathered from quantitative and qualitative primary research with executives at pharmaceutical companies. Subscribers to the Best Practice Database have access to these primary research results to make informed decisions in their functional areas. Within the documents, charts, graphs, and process maps enable executives to assess resource levels, responsibility scope, and performance metrics of their function.

To download a complimentary summary containing insights found in this document, click on the following link: http://www.best-in-class.com/dr356.htm.

For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
General information or questions:
kxinfo@kxnet.com

News:
Bismarck:
Phone: 701-223-9197
News Fax: 701-223-1985

News:
Minot:
Phone: 701-852-2104
News Fax: 701-838-1050
All content © Copyright 2000 - 2014 WorldNow and KXNET. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.